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Heparao sulfate proteoglycaos (HSPGs) are components of the 
basement membrane (BM) of various tissues. They consist of a 
core protein and negatively charged glycosaminoglycan side 
chains: the heparan sulfate (HS) moieties. 
In psoriasis, uninvolved skin of psoriasis patients and in 
normal skin, the distribution of HSPGs was studied immuno-
histochemically by means of three different monoclonal antibod-
ies: JM-72, directed against the HSPG-core protein, JM-13 
against the sulfated domains of HS and JM-403 against the 
unmodified/low sulfated parts of HS. 
ln psoriasis JM-13 staining was consistently absent in the tips 
of the dermal papillae, whereas JM-13 showed a continuous 
staining in the BM of uninvoh·ed and normal skin. JM-403 
staining was present in BM of aU specimens. In addition, a 
honeycomb-like staining was found in epidermis of normal skin 
and to a lesser extent in unimolved skin, due to binding with 
plasma membrane-associated HS. In psoriasis this JM-403 
staining of the epidermis was im·ariably absent. JM-72 showed 
a continuous staining of BM in aU biopsies. 
In conclusion, normal human skin and involved psoriatic skin 
show clear differences in expression of HS. These data may 
provide insight into the role of HSPGs in psoriasis, which 
remains further to be elucidated. Key words: dermo-epiderma/ 
junction; basement membrane; immunohistochemical; normal 
skin; uninvolved psoriasis. 
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Psoriasis is a hyperproliferative skin disease, the aetiology of 
which is still unknown. In the epide1mis of uninvolved skin of 
psoriasis patients, various changes have been described, but 
none of these have until now been shown to play the major 
role in the pathogenesis of psoriasis ( 1 ). Investigations of 
incipient psoriasic lesions and spreading psoriatic plaques have 
shown that even in very early lesions and in adjacent unin-
volved skin, changes can be detected in the stroma. Using 
laser D oppler flowmetry, Macdonald Hull et al. showed 
increased blood fiow that could be demonstrated before clinical 
lesions appeared (2). In addition, the endothelial marker 
enzyme alkaline phosphatase was distinctly increased 1 em 
outside spreading psoriatic plaques (3 ), and the extracellular 
matrix (ECM) protein tenascin was already found to be 
increased before clinical lesions appeared (4). 
In recent studies, the dermo-epidermal junction has received 
little attention. The basement membrane (BM) of the epi-
dermis is known to influence a series of important functions, 
such as keratinocyte differentiation, growth and migration. In 
addition, due to the assembly the EM-components and the 
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presence of anionic sites in the BM, the BM plays a role as a 
selective filtration barrier (5- 8). 
In psoriasis, the role of some BM-components was studied 
in detail (4, 9-12). An important component of the BM, 
which has never been studied before in psoriatic lesions, is 
heparan sulfate proteoglycan (HSPG). This member of the 
heterogeneous family of the proteoglycans is composed of 
glycosaminoglycan side chains, the negatively charged heparan 
sulfate (HS) moieties, that are covalently bound to a core 
protein ( 13, 14). There are two classes ofHSPGs: one class is 
present on the cell membrane of many cell types, the other 
class is expressed in the ECM and more specifically in BM 
( 14 ). The EM-associated HSPGs bind to laminin, fibronectin, 
collagen type IV and nidogen and therefore play an important 
role in BM assembly ( 15). Because of the negatively charged 
shield they block passage of anionic macromolecules through 
the BM. The storage of growth factors is considered to be an 
important function of HSPGs (5, 16). This storage of growth 
factors, the important role in BM assembly and the barrier 
function of HSPGs, combined with the fact that abnormal 
proliferation, differentiation and increase in transepidermal 
water loss are important characteristics of a psoriatic lesion 
(17, 18), pointed towards a possible change of HSPGs in 
psoriasis. 
Recently, three monoclonal antibodies clirected against the 
HSPGs have become available: monoclonal antibody JM-13, 
directed against the highly sulfated domains of HS, mAb 
JM-403, directed against the unmodified/ low sulfated parts of 
HS, and mAb JM-72, an antibody directed against the core 
protein of BM HSPGs. These antibodies enabled us to study 
the distribution of HSPG in detail. The aim of the present 
study was to investigate immunohistochemically the localis-
ation and distribution of HSPG-core protein and HSPG side 
chains in psoriatic lesions and to compare them to normal 
skin and uninvolved psoriatic skin. 
MATERIALS AND METHODS 
Patients and biopsies 
Twenty patients with psoriasis and 20 healthy volunteers participated 
in this study. The 20 patients suffering from psoriasis (7 women and 
13 men, age range 24- 72 years; mean 48.2 years) had used no topical 
treatment for at least 2 weeks, and no systemic anti-psoriatic therapy 
for at least I year. After local anaesthesia, a biopsy (cj>4 mm) from a 
psoriatic lesion was taken in 20 patients. In 6 patients, an additional 
biopsy was taken from a clinically uninvolved part of the skin, at a 
distance of at least 20 em from a lesion. 
In addition. biopsies were taken from the normal skin of 20 healthy 
volunteers without history or sign of skin disease (19 men and one 
woman, age range 25- 56 years; mean 29,9 years). 
Biopsies were embedded in Tissue Tek OCT compound (Miles 
Scientific. !':aperville, U.S.A.), snap frozen in liquid ni trogen and 
stored at -so•c. Tissues were sectioned at 7 ~tm and fixed in acetone 
(0°C) for 10 min and again stored at -so•c until use. 
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Permission to conduct this study was obtained from the local Ethic> 
Committee of the University Hospital Nijmegen. Informed consent 
was given by all subjects in this study. 
Amihodies 
For immunohistochemical stammg. three monoclonal antibodies 
against HSPG were used. mAb JM-72 ( 19). which tS directed against 
the BM- associated HSPG-core protein. and t\\O mAb>. designated as 
JM-13 (20) and JM-403 (21) against the HS-side chains. The produc-
tion, characterisation and demonstration of >pecificity of these mono-
clonal antibodies were carried out by van den Born et al., as previously 
published ( 19-21 ). The two mAbs JM-13 and JM-403 recognise 
different epitopes a long the HS polysaccharide chain: JM-13 binds to 
N-sulfated epitopcs in HS and heparin (which is closely related to HS 
but much more sulfated}: JM-403 preferentially binds to low-sulfated 
HS preparations. Moreover. the epitopc is fully dependent on the 
presence of an N-unsub~tituted glucosamine residue. thus having a 
free amino group. These units are not found in hyaluronic acid. 
thereby excluding binding of JM-403 to hyaluronic acid (22). In 
conclusion: mAb JM-13 binds to an epitope in the highly sulfated 
domains of HS and heparin, whereas mAb JM-403 binds to 
unmodified!low sulfated regions of HS. 
Immunohistochemical staining 
For all three antibodies an indirect peroxidase technique was used. 
Control stainings were carried out using nonimmune mouse lgG. 
Afler thawing at room temperature for 30 min, slides were fixed again 
in acetone (OcC) for 10 min, washed in phosphate-buffered saline 
(PBS) and incubated for I h at room temperature with the primary 
antibodies [anti HSPG-core mAb JM-72 (ascites, I :250 in PBS). anti 
HS mAb JM-403 (ascites. I :250) and anti HS mAb J M-13 (undiluted 
culture supernatant)]. 
After having been wa~hcd twice in PBS the slides were incubated 
for 30 min with a solution of rabbit-anti-mouse-immunoglobulins 
( DAKOPATIS. Copenhagen, Denmark) conjugated with peroxida~e. 
di luted I :50 in phosphate buffer containing 5% human AB-serum. 
After two further washes in PBS and a preincubation wi th sodium 
acetate buffer (pH 4.9), slides were stained in :1 solution of 3-amino-
9-ethyl-carbazole (AEC) in sodium acetate buffer containing 0.01% 
f-1 20 2 for 10 min. Slides were counterstained with Mayer's haematoxy-
lin (Sigma, StLouis, U.S.A.) and mounted in glycerin gelatin (Sigma. 
St Louis, U.S.A.). 
llisiOiogical examination 
The distribution of the stammg in dermis, epidermis and ba~al 
membrane was assessed by two independent investigators using a 
3-point scale: O=staining not present. I =discont inuously distributed 
staining, 2=continuously distributed staining. In addition, staining of 
BM of bloodvessels in the dermis was scored as being either present 
or absent and the presence of ceU membrane-associated staining was 
recorded as weU. 
RESULTS 
All control stainings using nonimmune mouse IgG were 
negative. 
JM-13 
All 20 specimens of psoriatic skin showed a striking staining 
pattern, completely different from the staining pattern in 
normal and uninvolved skin. JM- 13 staining was consistently 
absent in the tips of the dermal papillae. A clear. linear 
staining was present invariably in the lower parts of the dermal 
papillae ( F ig. lb). 
The JM-13 staining in all 20 specimens of normal skin 
showed a continuous staining of the BM at the dermo-
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Fig. /. Immunohistochemical detection of HS by mAb JM-13. ( a) 
Normal skin. (b) Psoriasis. Note absence of s taining in the tips of the 
dermal papi llae. 
epidermal junction ( Fig. Ia) . The clinically uninvolved skin of 
psoriatic patients showed a pattern that was similar to that 
observed in healthy volunteers. In contrast to the antibodies 
JM-403 and JM-72, mAb JM-1 3 only stained the BM of the 
dem10-epidermal junction and not the BM of the blood vessels. 
JM-403 
In all specimens from normal skin, JM-403 staining. directed 
against the unmodified/ low sulfated parts of HS, displayed a 
strong honeycomb-like staining in the epidermis (Fig. 2a). The 
staining pattern suggested staining of membrane-bound struc-
tures or intercellular substances. Thjs s taining pattern was 
most pronounced in the stratum spinosum and s tratum granu-
losum and was less prominent in the stratum corneum and 
basal layers. I n uninvolved epidermis of psoriatic patients the 
cell membrane associated staining was seen more focally and 
was less conspicuous, whereas this staining panern was invari-
ably absent in the lesional skin of all psoriatic patients 
(Fig. 2b). 
In the BM of skin a nd bloodvessels the JM-403 staining 
was bright, continuous and present in all specimens. 
JM-72 
Staining with the antibody JM-72, directed against the core 
protein of the HSPG, was positive in all specimens. In normal 
Fig. 2. Immunohistochemical staining of HS-side chains by mAb 
JM-403. ( a) Normal skin. Note the honeycomb-like staining in the 
epidermis. (b) Psoriasis. Note the absence of honeycomb-like staining. 
skin, uninvolved psoriasis and psoriatic lesions the staining 
was restricted to the BM of the dermal-epidermal junction 
and the BMs of the blood vessels in the dermis. There was a 
strong and continuous linear staining (Fig. 3). No additional 
structures were stained. 
DISCUSSION 
At present little is known about the distribution of HSPGs in 
human skin. In normal human epidermis, Tammi et al. 
localised keratinocyte surface-associated HSPGs by means of 
electron microscopy (23 ), and recently, van den Born et a!. 
described the expression of EM-associated HSPGs in normal 
human skin ( 19). 
In this study we analysed the distribution of HSPGs in 
psoriasis, uninvolved psoriasis and normal skin by means of 
immunohistochemical staining. Three new monoclonal anti-
bodies were used, two directed against the HS-side chains 
(JM-13 and JM-403) and one against the HSPG-core protein 
(JM-72) (19- 21). mAb JM-72 gave a continuous, similar 
staining in all specimens, indicating that the core protein of 
HSPG is present in normal skin, uninvolved psoriasis and 
psoriatic skin without a difference in distribution. This also 
applies to the staining of the BM by the mAb JM-403, directed 
against the HS-side chains, which also gave a bright, continu-
ous staining in all specimens. 
However, staining with JM -13, directed against a different 
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Fig. 3. Immunohistochemical detection of HSPG-core protein by mAb 
JM-72. (a) Normal skin. (b) Psoriasis. 
epitope on the HS-side chain, showed a clearly different pattern 
in all specimens. It was absent in the tips of the dermal papillae 
of all psoriasis specimens. The heterogeneity in staining of the 
HS-side chains by the two antibodies JM-13 and JM-403 can 
be explained by the different epitopes recognised. The epitope 
of JM-403 is located in the unmodified/ low sulfated domains 
ofHS. This is in contrast with the epitope of JM-13, which is 
located in the N-sulfated parts of HS-side chain. 
Several mechanisms can explain the absence of JM-13 
staining in the tips of the dermal papillae. This might be the 
result of decreased accessibility of HS due to epitope masking 
by cationic molecules or immune complexes, or alternatively 
the epitopes are lost due to enzymatic cleavage of HS. A third 
possibility could be a steric hindrance of BM components 
caused by changed molecular interactions. These three possibil-
ities are discussed below. 
In psoriasis, neutrophil polymorphonuclear leukocytes 
(PMNs) and plasma proteins move from the tip of the capillary 
loops in the dermal papillae into the epidermis (24, 25). Tt is 
striking to observe that in this part of the basal membrane, 
where the PMNs and plasma proteins pass, the JM-13 staining 
is absent. lt is tempting to assume a connection between these 
events. Maybe the JM-13 epitope is blocked by plasma andjor 
PMN-derived cationic proteins, remaining the unmodified/low 
sulfated regions in HS accessible for JM-403 binding. This 
mechanism has been described in previous studies on SLE-
nephritis, showing a binding of cross-reactive anti-nuclear 
antibodies to HS (26, 27). Recently, the adherence of leukocyte 
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integrin Mac-1 to heparan sulfate has been described (28). 
The adhesion to heparan sulfate of this integrin. which 
co-ordinates adhesive functions including leukocyte migration. 
strengthens this explanation for the absence of J M-13 staining. 
A second explanation might be the lytic action of inflammatory 
cells. such as PMNs. that may destroy the JM- 13 epitope. 
Thirdly. many interactions between the HS-side chain and the 
BM components fibronectin. laminin and collagen type IV are 
known. Battaglia et al. describe the formation of ternary 
complexes between laminin, nidogen and proteoglycan. sug-
gesting a key role for nidogen in basement membrane assembly 
( 15, 29 ). It could thus be that one of these interactions is 
changed in the tips of the dermal papillae in such a way that 
the accessibility of the J M-1 3 epitope is altered by steric 
hindrance of BM components. A previous study already found 
a general loss of BM integrity in psoriatic lesions (30) and b y 
electron microscopy, Cox (31) found foci of discontinuity in 
the basal lamina, especia lly in active lesions. 
A second interesting finding was the honeycomb-like stain-
ing of the epidermis with mAb JM-403 in nom1al skin and 
non-lesional psoriatic skin a nd the remarkable absence of this 
staining in psoriasis. M ost likely this is due to binding of the 
antibody to the kcratinocyte plasma membrane-associated 
HSPGs. In literature. h owever, such crossreactivity has never 
been described (32, 33 ). Two possible candidates of cell 
membrane-associated HSPGs in skin which share homologies 
with BM-associated HSPGs are syndecan and CD44v3. The 
possibility of staining of hyaluronic acid by mAb JM-403 was 
ruled out as the epitope of mAb JM-403 is fully dependent 
on the presence of an N-unsubstituted glucosarnine residue. 
thus having a free amino group. These units are not found in 
hyaluronic acid (22). 
Both CD44v3 and syndecan- 1 are known to play an import-
ant role in cell-cell interactions, ceii-ECM interactions and the 
binding of growth factors (34- 36). These biological function s 
are important in the regulation of cell growth and migration. 
Absence of either syndccan-1 o r C044v3 in the epidermis of 
a psoriatic lesion could contribute to changes in proliferation. 
differentiation a nd mig ration in psoriasis. 
In conclusion. an a ltered HSPG expression in psoriasis was 
described compared to normal skin, namely the absence of 
high sulfated H S-side c hains (JM-13) in the tips of the dermal 
papillae in psoriatic patients a nd the different staining pattern 
with mAb JM-403 against low sulfated HS-side chains in 
psoriasis compared to uninvolved and normal skin. 
To the best of our knowledge, these changes in HSPG 
expression in psoriasis have never been described before. These 
data may provide insight into the role of HSPGs in psoriasis. 
which remains further to be e lucidated. 
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